USPTO serial 88199889
ONEBIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 28, 2020
- Examiner
- SCHLEGELMILCH, JONATHON A
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with ONEBIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
CATALENT PHARMA SOLUTIONS, INC.
Somerset, NJ, US
CATALENT PHARMA SOLUTIONS, INC.
Somerset, NJ, US
CATALENT PHARMA SOLUTIONS, INC.
Somerset, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Vanessa A. Ignacio, Esq.
Vanessa A. Ignacio, Esq. LOWENSTEIN SANDLER LLPONE LOWENSTEIN DRIVEROSELAND, NJ 07068United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Supply chain management services; Business management services, namely, managing and optimizing logistics, supply chain services, supply chain synchronization, labeling, packaging and product distribution processes for others; Business management services, namely, managing logistics, reverse logistics, supply chain services, supply chain visibility and synchronization, supply and demand forecasting and product distribution processes for others; Distributorship services in the field of pharmaceuticals, biopharmaceuticals, radiopharmaceuticals, health care products and medical products | ACTIVE | — |
| 039 | Packaging of clinical, pharmaceutical and health care products to the order and specification of others | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CATALENT PHARMA SOLUTIONS, INC.
- Other trademarks owned by CATALENT PHARMA SOLUTIONS, INC.
- Other trademarks owned by CATALENT PHARMA SOLUTIONS, INC.
- Other trademarks in Class 035
- Other trademarks in Class 039
- Similar marks named ONEBIO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 9, 2026 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Apr 22, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Apr 22, 2026 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Apr 20, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 27, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jan 28, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jan 28, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 24, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 23, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 20, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 20, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 12, 2019 | IUAF | USE AMENDMENT FILED | — |
| Dec 12, 2019 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 18, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 23, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 23, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 3, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 21, 2019 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 19, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 18, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 18, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 11, 2019 | ALIE | ASSIGNED TO LIE | — |
| Mar 8, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 27, 2019 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Feb 27, 2019 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Feb 27, 2019 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Feb 27, 2019 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Feb 21, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 13, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 22, 2018 | NWAP | NEW APPLICATION ENTERED | — |